Lilly Zyprexa off-label use
Executive Summary
Lilly warns against Zyprexa off-label use in a Jan. 15 letter to physicians. The letter notes increased incidence of mortality and cerebrovascular events in elderly dementia patients...
You may also be interested in...
Antipsychotic Boxed Warning Will Caution Against Off-Label Use In Dementia
FDA is asking manufacturers of atypical antipsychotics to add a "black box" warning to labeling on an increased mortality risk associated with the drugs' off-label use to treat dementia-related behavioral disorders
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.